In a recent publication, Northwestern Medicine scientists and collaborators at Purdue University proposed a new marker to identify ovarian cancer stem cells, which may lead to the development of a new class of drugs that could target those cells for eradication.
The study, published in Cell Stem Cell, proposes a method for targeting cancer stem cells through metabolic markers. While cancer stem cells are a small population of all cancer cells, they have the ability to initiate tumors and have...
More